Principal Financial Group’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-760,608
| Closed | -$13M | – | 2268 |
|
|
2025
Q1 | $13M | Sell |
760,608
-31,255
| -4% | -$534K | 0.01% | 1114 |
|
|
2024
Q4 | $19.6M | Sell |
791,863
-159,261
| -17% | -$3.94M | 0.01% | 861 |
|
|
2024
Q3 | $27.1M | Buy |
951,124
+391,436
| +70% | +$11.2M | 0.01% | 682 |
|
|
2024
Q2 | $14.8M | Sell |
559,688
-23,033
| -4% | -$608K | 0.01% | 1047 |
|
|
2024
Q1 | $18.8M | Buy |
582,721
+142,606
| +32% | +$4.61M | 0.01% | 944 |
|
|
2023
Q4 | $18.5M | Buy |
440,115
+113,040
| +35% | +$4.76M | 0.01% | 925 |
|
|
2023
Q3 | $12.6M | Buy |
327,075
+303,707
| +1,300% | +$11.7M | 0.01% | 1093 |
|
|
2023
Q2 | $443K | Sell |
23,368
-684
| -3% | -$13K | ﹤0.01% | 1980 |
|
|
2023
Q1 | $373K | Buy |
24,052
+1,319
| +6% | +$20.5K | ﹤0.01% | 2037 |
|
|
2022
Q4 | $404K | Buy |
22,733
+4,896
| +27% | +$86.9K | ﹤0.01% | 2025 |
|
|
2022
Q3 | $99K | Buy |
17,837
+2,510
| +16% | +$13.9K | ﹤0.01% | 2336 |
|
|
2022
Q2 | $60K | Buy |
15,327
+2,293
| +18% | +$8.98K | ﹤0.01% | 2448 |
|
|
2022
Q1 | $72K | Sell |
13,034
-734
| -5% | -$4.06K | ﹤0.01% | 2458 |
|
|
2021
Q4 | $117K | Sell |
13,768
-5,694
| -29% | -$48.4K | ﹤0.01% | 2426 |
|
|
2021
Q3 | $169K | Sell |
19,462
-3,155
| -14% | -$27.4K | ﹤0.01% | 2452 |
|
|
2021
Q2 | $239K | Buy |
22,617
+3,094
| +16% | +$32.7K | ﹤0.01% | 2425 |
|
|
2021
Q1 | $313K | Sell |
19,523
-8,121
| -29% | -$130K | ﹤0.01% | 2265 |
|
|
2020
Q4 | $1.28M | Buy |
+27,644
| New | +$1.28M | ﹤0.01% | 1888 |
|